Harrow (HROW) Debt Ratio (2011 - 2026)
Harrow (HROW) posted Debt Ratio of 0.7 for Q2 2026, up 0.75% on a QoQ basis from 0.7 in Q1 2026, and up 8.97% year-over-year from 0.64 in Q2 2025.
Analysis
Harrow (HROW) Debt Ratio (2011 - 2026) Analysis & Trends
Harrow has reported Debt Ratio for 15 years, with the latest figure at 0.7 in Q2 2026.
- On a quarterly basis, Debt Ratio rose 8.97% year-over-year to 0.7 in Q2 2026; TTM through Jun 2026 was 0.7, a 8.97% increase from a year earlier, with the FY2025 full-year figure at 0.61, up 7.86% from the prior year.
- Debt Ratio was 0.7 for Q2 2026 at Harrow, up from 0.7 in the prior quarter.
- The five-year high for Debt Ratio was 0.78 in Q1 2023, with the low at 0.56 in Q4 2024.
- Average Debt Ratio over 5 years is 0.67, with a median of 0.65 recorded in 2022.
- The sharpest annual moves came in 2022 and 2024: Debt Ratio soared 276.6% in 2022, then decreased 20.36% in 2024.
- Over 5 years, Debt Ratio stood at 0.66 in 2022, then retreated by 10.04% to 0.6 in 2023, then fell by 5.22% to 0.56 in 2024, then grew by 7.86% to 0.61 in 2025, then gained by 15.23% to 0.7 in 2026.
- The last three Debt Ratio figures came in at 0.7 (Q2 2026), 0.7 (Q1 2026), and 0.61 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.53 Bn | 625.77 Bn | 17.26 Bn | 0.30 |
| 2 | AbbVie | 442.27 Bn | 435.70 Bn | 12.70 Bn | 0.52 |
| 3 | Merck | 366.81 Bn | 359.67 Bn | 12.21 Bn | 0.42 |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn | 0.08 |
| 5 | Pfizer | 159.37 Bn | 147.67 Bn | 10.94 Bn | 0.31 |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | 0.17 |
| 7 | Revolution Medicines | 44.12 Bn | 44.12 Bn | - | - |
| 8 | Incyte | 25.49 Bn | 20.95 Bn | 1.57 Bn | 0.00 |
| 9 | United Therapeutics | 21.55 Bn | 18.89 Bn | 683.80 Mn | - |
| 10 | Harrow | 1.40 Bn | 1.32 Bn | 50.36 Mn | 0.70 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.70 |
| Mar 31, 2026 | 0.70 |
| Dec 31, 2025 | 0.61 |
| Sep 30, 2025 | 0.67 |
| Jun 30, 2025 | 0.64 |
| Mar 31, 2025 | 0.61 |
| Dec 31, 2024 | 0.56 |
| Sep 30, 2024 | 0.63 |
| Jun 30, 2024 | 0.60 |
| Mar 31, 2024 | 0.62 |
| Dec 31, 2023 | 0.60 |
| Sep 30, 2023 | 0.64 |
| Jun 30, 2023 | 0.76 |
| Mar 31, 2023 | 0.78 |
| Dec 31, 2022 | 0.66 |
| Sep 30, 2022 | 0.73 |
| Jun 30, 2022 | 0.73 |
| Mar 31, 2022 | 0.74 |
| Dec 31, 2021 | 0.73 |
| Sep 30, 2021 | 0.66 |